Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal ID6440: Sirolimus gel for treating facial angiofibroma from tuberous sclerosis complex in people 6 years and older (review of TA972) |
|
Medicine details |
|
Medicine name | sirolimus (Hyftor®) |
Formulation | 2 mg/g gel |
Reference number | 4973 |
Indication | Treatment of facial angiofibroma associated with tuberous sclerosis complex in adults and paediatric patients aged 6 years and older. |
Company | Plusultra pharma |
BNF chapter | Skin |
Submission type | N/A |
Status | Excluded due to NICE appraisal |
Date of issue | 22/10/2024 |
NICE guidance |